This trial is !
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
and you are
under 5
years old
The phase for this study is not defined.
Show me locations

The purpose

This expanded access protocol is for children that cannot get enough nutrients from food and must receive nutrition through a vein. The standard nutrition given through a vein is blend that has soybean fat. If this is given over a long period of time, it can cause problems. It can lead to severe and/or permanent injury to the liver. It is believed that a type of fish oil blend, called Omegaven®, may be used in place of the soybean fat blend. The Omegaven® fish oil blend may greatly reduce the risk of liver injury. Omegaven® is not approved by the Food and Drug Administration (FDA). It is only offered under an "expanded access" protocol as an alternative to the soybean fat blend.

Provided treatments

  • Dietary: Omegaven
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02778698. The sponsor of the trial is Geisinger Clinic and it is looking for 0 volunteers for the current phase.
Official trial title:
Compassionate Use of an Intravenous Fat Emulsion Comprised of Fish Oil in The Treatment of Parenteral Nutrition Induced Liver Injury in Children